Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04390880 · ClinicalTrials.gov registry record · Phase 2
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer
A Phase 2 study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 239
- Enrollment target
NCT04390880 is a Phase 2 study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 239 participants.
The verdict
NCT04390880, a Phase 2 study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 239 participants
- Enrollment target
Study Summary
The main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical management plan in Veterans. In this study, the management plan prior to and after 18F-DCFPyL PET/CT will be recorded by specific questionnaires and corresponding changes in management will be analyzed. The scan will be used to see how the disease has spread. Both the treatment strategies and probable disease outcomes as relevant to clinical endpoints will be assessed. This study is open to Veterans only.
Interventions
- DRUG 18F-DCFPyL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2020-04-07 |
| Est. Completion | 2021-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04390880
The ClinicalTrials.gov registry entry for NCT04390880 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-DCFPyL is the first listed.
NCT04390880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04390880 about?
NCT04390880 is a clinical study titled "18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer". The main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical management plan in Veterans. In this study, the management plan prior to and after 18F-DCFPyL PET/CT will be recorded by spe...
What is the current status of trial NCT04390880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 239 participants. The study started on 2020-04-07. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04390880?
The interventions under investigation include: 18F-DCFPyL (DRUG).
Who is sponsoring clinical trial NCT04390880?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.